Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Search results

Showing results for

An internationally recognised centre of excellence for biomedical and clinical research and teaching

Oxford University spinout Dark Blue Therapeutics acquired to advance leukaemia treatment

Oxford University spinout Dark Blue Therapeutics has been acquired by global biotechnology company Amgen in a deal worth up to US$840 million, marking a major milestone for Oxford-led cancer research and innovation. The deal reflects years of collaborative, multidisciplinary work across the University and its partners to translate fundamental research into promising new medicines.

GSK, University of Oxford and Imperial College London launch centre to create computer models of lungs, liver, kidneys and cartilage

A new research centre backed with £11 million from GSK will build open-source digital twins of organs for in-silico research to advance disease understanding and speed up development of new drugs.

Oxford and Serum Institute of India sign IP license agreement to advance NipahB vaccine candidate

The University of Oxford and Serum Institute of India Pvt. Ltd. (SII), a Cyrus Poonawalla Group company and the world’s largest vaccine manufacturer, have signed an Intellectual Property license agreement to advance the development and manufacture of the ChAdOx1 NipahB vaccine candidate.

Guest Lecture series: Highlighting breakthroughs in women’s health and stillbirth prevention

The latest event of the Guest Lecture series welcomed Professor Sarah Stock, Programme Director of In Utero at Wellcome Leap, who delivered a compelling talk titled Breakthroughs in Women’s Health.

New Oxford-led initiative launches to train future leaders in transformative technologies for pharmaceutical research

GSK, in partnership with the Universities of Oxford, Cambridge and Southampton, has launched Transformative Technologies in Pharmaceutical Sciences (TTPS). This cross-sector doctoral training programme will equip a new generation of researchers to translate basic scientific research and biological understanding into novel technologies, vaccines, therapies and drugs that will accelerate patient benefit. The new programme is a part of the Industrial Landscape Award programme announced by BBSRC.

Oxford spinout launches AI-based ultrasound technology to improve early detection of pregnancy complications

A new University of Oxford spinout, Oxailis Ltd, has launched an AI-based ultrasound technology that enables healthcare professionals to measure perfusion (how effectively oxygen-rich blood is delivered to tissue), using existing standard ultrasound hardware and without the need for contrast agents.

NDORMS and NDCN collaborate with Oxford University Hospitals to form the Kadoorie Institute for Trauma, Emergency and Critical Care

Oxford Trauma and Emergency Care at Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS), along with the Critical Care Research Team at Nuffield Department of Clinical Neurosciences (NDCN) have formally become a new Institute within the University of Oxford: the Kadoorie Institute for Trauma, Emergency and Critical Care.

Oxford researchers join Novo, Gates, and Wellcome to tackle antimicrobial resistance

Oxford researchers from the Nuffield Department of Medicine are part of a major new international initiative with the Novo Nordisk Foundation, Wellcome and the Gates Foundation to accelerate the discovery of urgently needed antibiotics. The Gram-Negative Antibiotic Discovery Innovator (Gr-ADI) brings together global expertise to tackle drug-resistant Gram-negative infections, one of the most serious threats to global health.

Oxford cancer researchers welcome UK AI for Science Strategy, highlighting the opportunity for national AI-ready cancer data

Oxford researchers have welcomed the UK government’s new AI for Science Strategy, which sets out an ambitious plan to harness artificial intelligence, sovereign supercomputing and high-quality scientific data to accelerate discovery in the life sciences.

Oxford and GSK launch Experimental Medicine Collaboration

GSK invests £10 million over five years to establish the Experimental Medicine Collaboration with the University of Oxford.

Terumo completes acquisition of University of Oxford spinout OrganOx for a record $1.5bn

OrganOx, a pioneering Oxford University spinout transforming kidney and liver transplantation, has been fully acquired by Terumo Corporation, a global medical technology company headquartered in Tokyo, Japan, for US$1.5 billion, marking the largest exit in Oxford University’s spinout portfolio to date and the first in excess of £1bn. The agreement for the acquisition was announced in August 2025.

Innovative Oxford child anxiety treatment to be rolled out internationally

An effective online treatment for childhood anxiety developed by a team at the University of Oxford is to be adapted and tested in five countries in Asia and South America, with the aim of driving widespread implementation in the future.

Oxford’s OrganOx is shortlisted for the MacRobert Award 2025

The Royal Academy of Engineering has announced the finalists for the 2025 MacRobert Award, the longest running and most prestigious prize for UK engineering innovation.

New therapies developed by Oxford experts offer online support for anxiety and post-traumatic stress disorders

Four internet-based therapies developed by experts at the University of Oxford’s Department of Experimental Psychology and Department of Psychiatry are proving helpful for patients with social anxiety disorder and post-traumatic stress disorders and for children with anxiety disorders.

Oxford part of new international Pioneer Centre for medical data research

The University of Oxford has joined forces with Aarhus University and the University of Copenhagen to create a new Pioneer Centre that will become a significant international partner for data-driven medical research. The Pioneer Centre is anchored at Aarhus University with hub sites at each of the three universities and with a total grant of DKK 250 million.

Tech transfer partnership between universities creates company to transform care for millions of women

Amber Therapeutics (Tx), a start-up involving the University of Oxford, has just completed a $100 million Series A funding round from healthcare and technology investors in the US and UK to develop treatment for mixed urinary incontinence.

New Oxford quantum hub to tackle key challenges in quantum technologies

Today, the UK Government has announced the launch of five new research hubs to develop quantum technologies in areas ranging from healthcare and computing to national security and critical infrastructure. One of the hubs will be led by the University of Oxford, and aims to develop the technologies needed for the UK to play a key role in the development of quantum computers - a market estimated to be worth $1.3 trillion by 2035.

Yellowstone Biosciences spinout launches to advance cutting-edge cancer therapies

Yellowstone Biosciences, a biotechnology spinout, has launched to pioneer new cancer treatments using advanced T-cell therapies based on ground-breaking research from the MRC Weatherall Institute of Molecular Medicine at University of Oxford.

Serum Institute of India and University of Oxford strike landmark licensing agreement for Meningitis-B vaccine

Serum Institute of India Pvt. Ltd (SIIPL), in collaboration with the University of Oxford, is developing a novel solution for Men-B disease, advancing global accessibility to life-saving vaccines.

Oxford spinout Brainomix is revolutionising stroke care through AI

This year, around 100,000 people in the UK will have a stroke. AI algorithms developed by a University of Oxford spinout company are ensuring that more stroke patients will receive better care and outcomes.

Load More